Programmed cell death 4 (PDCD4) may play a role in radiotherapy-induced AKI in rectal cancer by upregulating FGR expression, activating the NF-κB signaling pathway, and triggering an oxidative stress response [206]. Here, PDCD4 is linked to rectal cancer.